BIIB091 is a potent, selective, and reversible inhibitor of Brutons tyrosine kinase (BTK) designed for research into autoimmune disorders. It is utilized in both in vitro biochemical assays and in vivo disease models to investigate B-cell receptor signaling pathways and therapeutic mechanisms.
Molekulargewicht:
542.648
CAS Nummer:
[2247614-80-6]
Formel:
C28H34N10O2
Target-Kategorie:
BTK,Others
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten